Recently, Penn's Center for Neurodegenerative Disease Research was one of the stops during an informational tour conducted for Philip Rubin, Principal Assistant Director for Science at The White House Office of Science and Technology Policy (OSTP), to demonstrate the breadth of brain-related research at Penn Medicine. Established in 1991 under the direction of Virginia Lee, PhD, MBA, and co-direction of John Trojanowski, MD, PhD, the Center for Neurodegenerative Disease Research (CNDR) is a multidisciplinary and collaborative Center at the Department of Pathology and Laboratory Medicine to promote and conduct clinical and basic research studies aimed at increasing understanding of the causes and mechanisms leading to brain dysfunction and degeneration in Alzheimer's disease (AD), Parkinson's disease (PD), Frontotemporal disease (FTD), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease), and other neurodegenerative disorders that occur more frequently with advancing age. The CNDR includes Department faculty members Kurt Brunden, PhD, Edward B. Lee, MD, PhD, Gerard Schellenberg, PhD, Les Shaw, PhD, and Vivianna van Deerlin, MD, PhD.

Read more about the visit on the Penn Medicine news blog.